Letter: The Addition of an Immunosuppressant in Patients With Unsatisfactory Response to Vedolizumab-Authors' Reply

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14570
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Letter: The Addition of an Immunosuppressant in Patients With Unsatisfactory Response to Vedolizumab

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: Can Addition of an Immunomodulator Really Reverse Antibody Formation and Loss of Response in Patients Treated With Adalimumab? Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Letter: Vedolizumab for Autoimmune Liver Disease Associated Inflammatory Bowel Disease-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: Elderly AIH Patients-An Important Subgroup. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Letter: Addition of Methotrexate Neither Restores Clinical Response Nor Improves the Pharmacokinetic Profile of Vedolizumab-Treated Patients

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Authors Reply Letter to the Reviewers

2020English

Letter: Vedolizumab Drug Levels in Cord and Maternal Blood in Women With Inflammatory Bowel Disease-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Prednisolone Response in Patients With COPD * Authors' Reply

Thorax
PulmonaryRespiratory Medicine
2004English

Letter: Limitations of Defecography Among Patients With Refractory Constipation. Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy